Go Pro
→ Buffett's Final Warning: 'The Dollar Is Going to Hell' (From Decentralized Masters) (Ad)tc pixel Free MIRM Stock Alerts

Mirum Pharmaceuticals (MIRM) Earnings Date, Estimates & Call Transcripts

Mirum Pharmaceuticals logo
$97.92 -0.86 (-0.87%)
As of 10:43 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Mirum Pharmaceuticals Earnings Summary

Mirum Pharmaceuticals announced Q2 2026 earnings on August 5, 2026, reporting an EPS of -$1.06, which missed analysts' consensus estimates of -$0.74 by $0.32. Quarterly revenue rose 37.9% year-over-year to $176.24 million, above analysts' expectations of $166.33 million. With a trailing EPS of -$14.55, Mirum Pharmaceuticals' earnings are expected to grow next year, from ($1.31) to ($0.46) per share.

Latest Q2
Earnings Date
Aug. 5Estimated
Consensus EPS
(Aug. 5)
-$0.74
Actual EPS
(Aug. 5)
-$1.06 Missed By -$0.32
Actual Revenue
(Aug. 5)
$176.24M

Q2 2026 Earnings Resources

Powered by Quartr
Get Mirum Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mirum Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

MIRM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MIRM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Mirum Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue Guidance
Q1 20261-$0.26-$0.26-$0.26
Q2 20261-$0.58-$0.58-$0.58
Q3 20261-$0.31-$0.31-$0.31
Q4 20261-$0.12-$0.12-$0.12
FY 2026 4 -$1.27 -$1.27 -$1.27
Q1 20271$0.08$0.08$0.08
Q2 20271$0.16$0.16$0.16
Q3 20271$0.40$0.40$0.40
Q4 20271$0.64$0.64$0.64

Mirum Pharmaceuticals Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/5/2026Q2 2026-$0.7425-$1.06 -$0.3175-$1.06$166.33M$176.24M
5/6/2026Q1 2026-$0.75-$13.43 -$12.68-$13.43$148.21M$159.88M
2/25/2026Q4 2025$0.02-$0.11 -$0.13-$0.12$141.78M$148.93M
11/4/2025Q3 2025-$0.10$0.05+$0.15$0.05$130.11M$133.01M
8/6/2025Q2 2025-$0.31-$0.12+$0.19-$0.12$107.91M$127.79M
5/14/2025Q1 2025-$0.35-$0.30+$0.05-$0.30$98.47M$111.59M
2/26/2025Q4 2024-$0.27-$0.49 -$0.22-$0.49$96.64M$99.41M
11/12/2024Q3 2024-$0.45-$0.30+$0.15-$0.30$81.99M$90.38M

Mirum Pharmaceuticals Earnings - Frequently Asked Questions

Mirum Pharmaceuticals (NASDAQ:MIRM) last announced its quarterly earning data on Wednesday, August 5, 2026. Learn more on MIRM's earnings history.

Mirum Pharmaceuticals updated its FY 2026 earnings guidance on Wednesday, August, 5th. The company issued revenue guidance of $680.0 million-$700.0 million, compared to the consensus revenue estimate of $675.1 million.

In the previous quarter, Mirum Pharmaceuticals (NASDAQ:MIRM) missed the analysts' consensus estimate of ($0.74) by $0.32 with a reported earnings per share (EPS) of ($1.06). Learn more on analysts' earnings estimate vs. MIRM's actual earnings.

The conference call for Mirum Pharmaceuticals' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Mirum Pharmaceuticals' latest earnings report can be read online.
Read Transcript

Mirum Pharmaceuticals' earnings report can be found in their filing with the SEC.
View SEC filing

Mirum Pharmaceuticals (NASDAQ:MIRM) has a recorded annual revenue of $521.31 million.

Mirum Pharmaceuticals (NASDAQ:MIRM) has a recorded net income of -$23.36 million. MIRM has generated -$14.55 earnings per share over the last four quarters.

Mirum Pharmaceuticals' earnings are expected to grow from ($1.31) per share to ($0.46) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:MIRM is sourced from Fiscal.ai, with the most recent quarter reported on 8/5/2026. New results are added as companies report their earnings.
From Our Partners
American retirees will miss THIS. Big Banks just moved in.
Central banks spent nearly $130 billion on physical gold last year, on top of $145 billion the year before. Q1...
Cedar Gold Group | Sponsoredtc pixel
The options guide that actually starts at the beginning
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Buffett's Final Warning: "The Dollar Is Going to Hell"
In 2025, the dollar lost 12% in value. Real inflation hit 5%+. 12% + 5% = 17% purchasing power gone. And it's ...
Decentralized Masters | Sponsoredtc pixel
After KDA, PRE, and OCEAN—this is the one
17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...
Crypto 101 Media | Sponsoredtc pixel
How the JPMorgan $8,000 Gold Call Exposed the Biggest Mistake in Most Retirement Accounts
JPMorgan has raised its 2026 gold forecast to $6,300, with a credible path to $8,000, and now calls gold a cor...
Golden Crest Metals | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel